Phenylalanine hydroxylase undergoes an obligatory prereduction step in order to become catalytically active as shown by stopped-flow kinetics and by measuring tyrosine formation at limiting 6-methyltetrahydropterin levels. This initial step requires oxygen and involves conversion of 6-methyltetrahydropterin directly to the quinonoid form with or without phenylalanine. The EPR spectrum of the resting enzyme (geff = 9.4-8.7, 4.3 and geff = 6.7, 5.4) is consistent with two species possessing distinctively different ligand environments for the non-heme, high-spin Fe3+. The intensity of the geff congruent to 4.3 feature is inversely proportional to the specific activity of the enzyme, whereas the intensity of the geff congruent to 6.7-5.4 region correlates with the activity of the enzyme. The latter features are lost upon addition of phenylalanine under anaerobic or aerobic conditions. In the presence of o-phenanthroline, the operation of the prereduction step results in nearly quantitative trapping of the iron in an Fe2+ redox state. Dithionite can substitute for 6-methyltetrahydropterin in an anaerobic prereduction step, generating a catalytically active phenylalanine hydroxylase containing Fe2+ that functions aerobically to produce tyrosine from added 6-methyltetrahydropterin in a 1/1 stoichiometry. Reductive titration of the hydroxylase by dithionite is consistent with the addition of one electron/subunit for coupled turnover. The implications of these findings for the mechanism of action of this enzyme are briefly discussed.
No takes yet. Share an insight, caveat, or question.
Wallick et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: